Technetium-99m-sestamibi scintimammography of benign and malignant phyllodes tumors
- 38 Downloads
We presented two cases of phyllodes tumor of the breast examined by99mTc-sestamibi (MIBI) two-phase scintimammography. In the case with malignant phyllodes tumor,99mTc-MIBI accumulation was recognized on both early and delayed images. In the case with benign phyllodes tumor, however,99mTc-MIBI accumulation was recognized on only the early image.99mTc-MIBI delayed imaging may have the potential to distinguish between benign and malignant phyllodes tumors.
Key wordstechnetium-99m-sestamibi scintimammography phyllodes tumor
Unable to display preview. Download preview PDF.
- 1.Rosen PP, Oberman HA. Cystosarcoma phyllodes.In Atlas of Tumor Pathology: Tumors of the Mammary Gland, Rosai J, Sobin LH (eds.), Washington DC, Armed Forces Institute of Pathology, pp. 107–114, 1993.Google Scholar
- 8.Moretti JL, Caglar M, Boaziz C, Calliat-Vigneron N, Morere JF. Sequential functional imaging with technetium-99m hexakis-2-methoxyisobutylisonitrile and indium-111 octreotide: can we predict the response to chemotherapy in small cell lung cancer?Eur J Nucl Med 22: 177–180, 1995.PubMedCrossRefGoogle Scholar
- 11.Komori T, Matsui R, Adachi I, Shimizu T, Sueyoshi K, Narabayashi I.In vitro uptake and release of201T1 and99mTc-MIBI in HeLa cell.KAKU IGAKU (Jpn J Nucl Med) 32: 651–658, 1995.Google Scholar